Xeris Pharmaceuticals Inc (XERS)

NASDAQ
2.070
+0.070(+3.50%)
After Hours
1.900
-0.170(-8.213%)
- Real-time Data
  • Volume:
    1,653,522
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    1.940 - 2.125

XERS Overview

Prev. Close
2
Day's Range
1.94-2.125
Revenue
35.34M
Open
2
52 wk Range
1.77-7.94
EPS
-1.51
Volume
1,653,522
Market Cap
279.34M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
3,069,726
P/E Ratio
-
Beta
1.82
1-Year Change
-62.76%
Shares Outstanding
134,947,843
Next Earnings Date
Mar 09, 2022
What is your sentiment on Xeris Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

Xeris Pharmaceuticals Inc Company Profile

Employees
180

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. It markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for primary periodic paralysis. The company also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was founded in 2005 and is headquartered in Chicago, Illinois.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuySellSellStrong Sell
Technical IndicatorsStrong BuyBuyBuyStrong SellStrong Sell
SummaryStrong BuyBuyNeutralStrong SellStrong Sell
  • Another Red day. It's great to buy at these low prices. I just hope it will recover before I run out of money or own it.
    0
    • Patience is key when investing here. Huge shorting, and FUD it's enough to create doubt. Just remember to DD and you will feel better about your decision
      1
      • I've been researching this Company all day. Investing now. Here's a link to some info if you're interested.https://1drv.ms/f/s!AtO4hLISyqu2gqAeKyTh59EUVDBCrw
        0
        • great research. thanks for sharing. I have been buying this stock from $1.9 price onwards. while the company seems to be generating all the right news, we are yet to see all these FDA approvals convert into Revenue and Profits. Hoping 2022 to be the year for that.
          0
        • great research. thanks for sharing. I have been buying this stock from $1.9 price onwards. while the company seems to be generating all the right news, we are yet to see all these FDA approvals convert into Revenue and Profits. Hoping 2022 to be the year for that.
          0
      • I bought 44444 at 2.57. Teik proffit - 7.99
        0
        • I need bitcoin any one have
          6
          • https://seekingalpha.com/news/3729101-xeris-shares-surge-12-on-fda-greenlight-for-levothyroxine-hypothyroidism-study
            0
            • Any update about this stock
              1
              • Only going down. Such a disappointment
                1
                • Hello to all. I had stocks of Xers a long time ago and I am back to get some now. I saw the earning. What are we waiting regarding the future if someone can summarize. Thanks in advanced
                  0
                  • huge uptrend here ... option call strike 10$ with big volume ... no worries next stop 10$-12$ ...
                    0
                    • The marketing authorisation is valid in all 27 countries of the European Union, plus Iceland, Norway, and Liechtenstein. As the EC decision was received after the end of the Brexit transition period, Xeris will complete a further administrative step in order to obtain a license in Great Britain. No re-examination of clinical data by the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) is expected.
                      0
                      • Lets go!!!!!
                        0
                        • Xeris Pharmaceuticals Receives European Commission Approval of Ogluo™ (glucagon) Injection for the Treatment of Severe Hypoglycaemia in Adults, Adolescents, and Children Aged 2 Years and Over With Diabetes Mellitus
                          0
                          • why skyrocket?
                            0
                            • I wish there is no massive sell off after opening 🙏
                              0
                              • I would buy more then. FDA approval by EU happened
                                0
                            • target above 10$
                              0
                              • XERIS is the 2021 best small cap investment acc. JAMES "REV SHARK" DEPORRE. https://realmoney.thestreet.com/investing/stocks/my-top-small-cap-play-for-2021-15532937?puc=yahoo&cm_ven=YAHOO
                                0
                                • Could you drop a link which is working?
                                  0
                                • not possible here. You can get it directly in the Webull - Xeris stock - news
                                  0
                              • this will fly. 3 FDA approval for January + partnership for diazepam.
                                0
                                • don't stop kitty kitty
                                  0
                                  • go baby go! to the moon
                                    0
                                    • sail away sail away ummmm. enigma
                                      0
                                      • just bought in just bought a ticket for this ride! take off at 9:30 all aboard
                                        0
                                        • Load the Boat
                                          0
                                          • XERS - Xeris Pharmaceuticals Announces Distribution Agreement With Megapharm Ltd. to Commercialize Gvoke in Israel and the Palestinian Authority
                                            0
                                            • BOOM !!! 🚀🚀🚀Xeris Pharmaceuticals Announces Distribution Agreement With Megapharm Ltd. to Commercialize Gvoke® in Israel and the Palestinian AuthorityDecember 22, 2020 07:00 AM Eastern Standard Time
                                              0
                                              Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                              Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.